News
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
Doctors say there's no reason to believe the new variant will cause any more severe illness than previous mutations of the ...
A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children ...
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
The FDA is planning a major shift in COVID-19 vaccine policy limiting future shots to seniors and high-risk groups while calling for more data on younger healthier populations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results